| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |